A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Gillian A. Horne, Jon Stobo, Caroline Kelly, Arunima Mukhopadhyay, Ayşe Latif, Judith Dixon-Hughes, Lynn McMahon, Pascale Cony‐Makhoul, Jenny Byrne, Graeme Smith,

Leukemia · 2020 · 77 citations · 37 references

DOIFull text

Open access

Concepts

References

37